Cargando…
Gastric Bypass Surgery Produces a Durable Reduction in Cardiovascular Disease Risk Factors and Reduces the Long‐Term Risks of Congestive Heart Failure
BACKGROUND: Obesity and its association with reduced life expectancy are well established, with cardiovascular disease as one of the major causes of fatality. Metabolic surgery is a powerful intervention for severe obesity, resulting in improvement in comorbid diseases and in cardiovascular risk fac...
Autores principales: | Benotti, Peter N., Wood, G. Craig, Carey, David J., Mehra, Vishal C., Mirshahi, Tooraj, Lent, Michelle R., Petrick, Anthony T., Still, Christopher, Gerhard, Glenn S., Hirsch, Annemarie G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524077/ https://www.ncbi.nlm.nih.gov/pubmed/28536154 http://dx.doi.org/10.1161/JAHA.116.005126 |
Ejemplares similares
-
All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes
por: Lent, Michelle R., et al.
Publicado: (2017) -
Clinical factors associated with weight loss outcomes after Roux-en-Y gastric bypass surgery
por: Still, Christopher D., et al.
Publicado: (2014) -
CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading
por: Chu, Xin, et al.
Publicado: (2018) -
A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains
por: Wood, G. Craig, et al.
Publicado: (2017) -
A Patient-Centered Electronic Tool for Weight Loss Outcomes after Roux-en-Y Gastric Bypass
por: Wood, G. Craig, et al.
Publicado: (2014)